缺血型烟雾病自发颈外动脉代偿的研究进展

刘红优; 吉四辈

缺血型烟雾病自发颈外动脉代偿的研究进展

刘红优,
吉四辈^,

新乡医学院第一附属医院河南新乡　453100

基金项目: 河南省科技厅科技攻关项目(172102310685)；河南省神经修复重点实验室开放课题(HNSIXF-2018-010)。

详细信息

作者简介:
刘红优，男，在读硕士，主治医师。研究方向：脑血管病基础与临床。Email：hongyou8726@163.com

通讯作者:
吉四辈，男，主任医师，硕士生导师。Email：jisibei@aliyun.com

中图分类号: R651.1
计量
- 文章访问数: 78
- HTML全文浏览量: 46
- PDF下载量: 5
- 被引次数: 0
出版历程
- 收稿日期: 2022-09-04
- 网络出版日期: 2023-04-04

Research advances in spontaneous external carotid artery compensation in patients with ischemic moyamoya disease

LIU Hongyou,
JI Sibei^,

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan Province, China

More Information

Corresponding author: JI Sibei. Email: jisibei@aliyun.com

摘要

摘要: 缺血型烟雾病自发颈外动脉代偿作为颅内Willis环区域动脉狭窄闭塞后的旁路或代偿性供血途径，对脑组织灌注起着极其重要的作用，对缺血性脑血管病患者的预后有积极影响。近年来，对烟雾病颈外动脉代偿进行了较多研究，本文对缺血型烟雾病自发颈外动脉代偿的的相关研究进行总结，为进一步明确代偿血管的始动和增生机制提供研究基础。
- 缺血型 /
- 烟雾病 /
- 侧支循环 /
- 自发颈外动脉代偿.
Abstract: Spontaneous external carotid artery compensation for ischemic moyamoya disease (MMD) as a bypass or compensatory blood supply pathway during progressive stenosis at the terminal portion of the internal carotid artery, plays an extremely important role in cerebral tissue perfusion and has a positive effect on the prognosis of patients with ischemic cerebrovascular disease. In recent years, there are many studies on external carotid artery compensation in MMD. This article summarizes the relevant studies on spontaneous external carotid artery compensation in ischemic MMD, providing a research basis for further clarifying the initiation and proliferation mechanism of compensatory vessels.
- ischemic /
- moyamoya disease /
- collateral circulation /
- spontaneous external carotid artery compensation

HTML全文

参考文献(35)

[1]	Shang SL,Zhou D,Ya JY,et al. Progress in moyamoya disease[J]. Neurosurg Rev,2020,43(2): 371-382. doi: 10.1007/s10143-018-0994-5
[2]	Ihara M,Yamamoto Y,Hattori Y,et al. Moyamoya disease:diagnosis and interventions[J]. Lancet Neurol,2022,21(8): 747-758. doi: 10.1016/S1474-4422(22)00165-X
[3]	Jauch EC,Saver JL,Adams HP Jr,et al. Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke,2013,44(3): 870-947. doi: 10.1161/STR.0b013e318284056a
[4]	Liebeskind DS. Collateral circulation[J]. Stroke,2003,34(9): 2279-2284. doi: 10.1161/01.STR.0000086465.41263.06
[5]	Maguida G, Shuaib A. Collateral circulation in ischemic stroke: an updated review[J/OL].https: //doi.org/10.5853/jos.2022.02936.
[6]	中国卒中学会脑血流与代谢分会. 缺血性卒中脑侧支循环评估与干预中国指南(2017)[J]. 中华内科杂志,2017,56(6): 460-471. doi: 10.3760/cma.j.issn.0578-1426.2017.06.016
[7]	Hendrikx G,Vöö S,Bauwens M,et al. SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease[J]. Eur J Nucl Med Mol Imaging,2016,43(13): 2433-2447. doi: 10.1007/s00259-016-3480-8
[8]	Fang H,Song B,Cheng B,et al. Compensatory patterns of collateral flow in stroke patients with unilateral and bilateral carotid stenosis[J]. BMC Neurol,2016,16: 39. doi: 10.1186/s12883-016-0560-0
[9]	Fujimura M,Tominaga T,Kuroda S,et al. 2021 Japanese guidelines for the management of moyamoya disease:guidelines from the research committee on moyamoya disease and Japan stroke society[J]. Neurol Med Chir (Tokyo),2022,62(4): 165-170. doi: 10.2176/jns-nmc.2021-0382
[10]	刘文华,倪冠中,黄显军,等. 成年型烟雾病侧支循环的分布模式[J]. 中华神经科杂志,2012,45(3): 149-153. doi: 10.3760/cma.j.issn.1006-7876.2012.03.002
[11]	Abumiya T,Fujimura M. The pathogenetic mechanism for moyamoya vasculopathy including a possible trigger effect of increased flow velocity[J]. JMA J,2023,6(1): 16-24.
[12]	Zhao M,Zhang D,Wang S,et al. The collateral circulation in moyamoya disease:a single-center experience in 140 pediatric patients[J]. Pediatr Neurol,2017,77: 78-83. doi: 10.1016/j.pediatrneurol.2017.08.016
[13]	Kim SJ,Son TO,Kim KH,et al. Neovascularization precedes occlusion in moyamoya disease:angiographic findings in 172 pediatric patients[J]. Eur Neurol,2014,72(5/6): 299-305.
[14]	Poggesi A,Pasi M,Pescini F,et al. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease:a review[J]. J Cereb Blood Flow Metab,2016,36(1): 72-94. doi: 10.1038/jcbfm.2015.116
[15]	Vinci MC,Carulli E,Rurali E,et al. The long telling story of “endothelial progenitor cells”:where are we at now?[J]. Cells,2022,12(1): 112. doi: 10.3390/cells12010112
[16]	Tinelli F,Nava S,Arioli F,et al. Vascular remodeling in moyamoya angiopathy:from peripheral blood mononuclear cells to endothelial cells[J]. Int J Mol Sci,2020,21(16): 5763. doi: 10.3390/ijms21165763
[17]	Alwjwaj M,Kadir RRA,Bayraktutan U. The secretome of endothelial progenitor cells:a potential therapeutic strategy for ischemic stroke[J]. Neural Regen Res,2021,16(8): 1483-1489. doi: 10.4103/1673-5374.303012
[18]	Gürler G,Soylu KO,Yemisci M. Importance of pericytes in the pathophysiology of cerebral ischemia[J]. Noro Psikiyatr Ars,2022,59(Suppl 1): S29-S35.
[19]	Dordoe C,Chen KY,Huang WT,et al. Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke[J]. Front Pharmacol,2021,12: 671131. doi: 10.3389/fphar.2021.671131
[20]	Ma YH,Zechariah A,Qu Y,et al. Effects of vascular endothelial growth factor in ischemic stroke[J]. J Neurosci Res,2012,90(10): 1873-1882. doi: 10.1002/jnr.23088
[21]	Manuel GE,Johnson T,Liu D. Therapeutic angiogenesis of exosomes for ischemic stroke[J]. Int J Physiol Pathophysiol Pharmacol,2017,9(6): 188-191.
[22]	Li JC,Jin MY,Sun XY,et al. Imaging of moyamoya disease and moyamoya syndrome:current status[J]. J Comput Assist Tomogr,2019,43(2): 257-263. doi: 10.1097/RCT.0000000000000834
[23]	Guo X,Yuan XX,Gao LY,et al. Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome:evaluation by computed tomography perfusion imaging[J]. Eur Radiol,2021,31(11): 8364-8373. doi: 10.1007/s00330-021-07960-4
[24]	Li JZ,Zhang Y,Yin D,et al. CT perfusion-based delta-radiomics models to identify collateral vessel formation after revascularization in patients with moyamoya disease[J]. Front Neurosci,2022,16: 974096. doi: 10.3389/fnins.2022.974096
[25]	Ya JY,Zhou D,Ding JY,et al. High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis[J]. Ann Transl Med,2020,8(4): 87. doi: 10.21037/atm.2019.12.140
[26]	Tsivgoulis G,Katsanos AH,Sharma VK,et al. Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke[J]. Neurology,2016,86(12): 1103-1111. doi: 10.1212/WNL.0000000000002493
[27]	Malhotra K,Safouris A,Goyal N,et al. Association of statin pretreatment with collateral circulation and final infarct volume in acute ischemic stroke patients:a meta-analysis[J]. Atherosclerosis,2019,282: 75-79. doi: 10.1016/j.atherosclerosis.2019.01.006
[28]	Li WX,Wei D,Xie XM,et al. Dl-3-n-Butylphthalide regulates the Ang-1/Ang-2/Tie-2 signaling axis to promote neovascularization in chronic cerebral hypoperfusion[J]. Biomedecine Pharmacother,2019,113: 108757. doi: 10.1016/j.biopha.2019.108757
[29]	Wang JH,Li YY,Yu HH,et al. Dl-3-N-butylphthalide promotes angiogenesis in an optimized model of transient ischemic attack in C57BL/6 mice[J]. Front Pharmacol,2021,12: 751397. doi: 10.3389/fphar.2021.751397
[30]	Zhao HR,Yun WW,Zhang QY,et al. Mobilization of circulating endothelial progenitor cells by dl-3-n-butylphthalide in acute ischemic stroke patients[J]. J Stroke Cerebrovasc Dis,2016,25(4): 752-760. doi: 10.1016/j.jstrokecerebrovasdis.2015.11.018
[31]	欧阳欣,胡巧霞,高大鹏. 丁苯酞注射液对急性脑梗死合并颅内动脉狭窄患者颅内动脉血流动力学、氧化应激及血清Hcy和CysC水平的影响[J]. 中国老年学杂志,2020,40(12): 2485-2487. doi: 10.3969/j.issn.1005-9202.2020.12.006
[32]	Kimmel ER,Al Kasab S,Harvey JB,et al. Absence of collaterals is associated with larger infarct volume and worse outcome in patients with large vessel occlusion and mild symptoms[J]. J Stroke Cerebrovasc Dis,2019,28(7): 1987-1992. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.032
[33]	Kuroda S,Nakayama N,Yamamoto S,et al. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease[J]. J Neurosurg,2020,134(3): 909-916.
[34]	Kim DY,Son JP,Yeon JY,et al. Infarct pattern and collateral status in adult moyamoya disease:a multimodal magnetic resonance imaging study[J]. Stroke,2017,48(1): 111-116. doi: 10.1161/STROKEAHA.116.014529
[35]	Lai PMR,Gomez-Paz S,Patel NJ,et al. Asymptomatic moyamoya disease in a North American adult cohort[J]. World Neurosurg,2022,161: e146-e153. doi: 10.1016/j.wneu.2022.01.076